Organization
A click of a figure displays the expansion version.
|
 |
Corporate Ethics Committee
Ensures corporate ethics and statutes are complied with in accordance with the JPMA Member Company Charter and Compliance Program Guidelines.
Promotion Code Committee
Coordinates with organizations such as Fair Trade Council, relevant governmental bodies and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), and other related JPMA committees to ensure compliance with the Ethical Drug Promotion Code.
Optimizes dissemination of information on ethical drugs and reviews member companies' product information brochures, advertisements, and related published information. Distribution Improvement Committee
Aims for accountable and efficient distribution of drug products in coalition with other JPMA committees and related organizations and governmental bodies. Undertakes surveys and studies on drug product distribution for policy and strategy proposal.
Drug Evaluation Committee
Promotes appropriate measures for research and development of new drugs, post-marketing safety measures, and appropriate use of drugs.
Proposes policies and strategies to enterprises, regulatory authorities, and society in general.
Regulatory Affairs Committee
Investigates regulatory affairs, including issues on implementation of the Pharmaceutical Affairs Law, examination of new drugs for approval, safety measures and so on. Proposes new policies and strategies on pharmaceutical administration, including measures for greater efficiency of business activities and more rapid review for new drug approval.
Quality & Technology Committee
Conducts surveys and studies on good manufacturing practice (GMP), pharmaceutical production technology, and related topics. Develops guidelines in coalition with the International Conference on Harmonisation (ICH) Project Committee within the framework of trilateral harmonization (Japan, US, and EU) and measures to improve reliability and quality of pharmaceutical products.
Intellectual Property Committee
Coordinates with relevant governmental bodies and other organizations to make Japan an intellectual property-based nation. Proposes new policies and strategies to establish a virtual cycle of creation, protection, and utilization of intellectual property worldwide.
R&D Committee
Improves the infrastructure for medicinal research including introduction of new technology.
Promotes industry-academia-government coalitions to stimulate transfer technology from academia to the pharmaceutical industry and train professionals.
International Trade Committee
Collects domestic and overseas information and takes appropriate measures on issues related to importation, exportation, and customs duties of medicines and intermediate medicinal products in coalition with related organizations. Takes prompt action to address issues related to the trade of medicines, drug substances, bulk powder, and raw materials.
International Affairs Committee
Exchanges information with the IFPMA, pharmaceutical associations/organizations in foreign countries, foreign public bodies/institutions, and others, and supports internationalization of the Japanese pharmaceutical industry to contribute to global healthcare. Takes action to facilitate public-private sector partnerships to support developing countries.
Environment & Safety Committee
Defines best practice models for global environment preservation and occupational safety and health management. Supports member companies' measures on the environment and safety.
Prepares and publishes JPMA Environmental Reports annually in dialogue with outside organizations.
Consumer Consultation Services Committee
Improves drug-related consultation systems for consumers, working together with the consumer drug consultation services provided by the Pharmaceuticals and Medical Devices Agency (PMDA), to ensure proper use of medicines.
Public Affairs Committee
Promotes activities oriented towards the goal of gaining extensive recognition as a “visible industry” and an “industry contributing to global healthcare.” Develops activities to improve public recognition and understanding of medicines and the pharmaceutical industry.
Takes action to facilitate adoption and implementation of JPMA strategies and policies.
Office of Pharmaceutical Industry Research (OPIR)
Conducts research on medium to long term strategic policies and individual topics for contribution of the pharmaceutical industry to society.
Center for Pharmaceutical Publication
Publishes and distributes the results of activities of JPMA committees and surveys. Organizes various seminars, meetings, and lectures on behalf of JPMA committees.
|
